Q&A

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...

In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.

In this Q and A, Supriya Mishra, MD, discusses the relationship between psoriatic arthritis and periodontitis, including how these conditions may adversely impact patients’ quality of life.

Despite several medical therapies currently available to treat Crohn disease, many patients still undergo surgical treatment. Benjamin Cohen, MD, co-section head and clinical director of the Department of...

In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...

In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...